nodes	percent_of_prediction	percent_of_DWPC	metapath
Rimonabant—CNR1—muscle cancer	0.917	1	CbGaD
Rimonabant—CYP1A2—Dacarbazine—muscle cancer	0.03	0.404	CbGbCtD
Rimonabant—CYP1A2—Etoposide—muscle cancer	0.0147	0.198	CbGbCtD
Rimonabant—CYP3A4—Vincristine—muscle cancer	0.00839	0.113	CbGbCtD
Rimonabant—CYP2D6—Doxorubicin—muscle cancer	0.00825	0.111	CbGbCtD
Rimonabant—CYP3A4—Etoposide—muscle cancer	0.00769	0.104	CbGbCtD
Rimonabant—CYP3A4—Doxorubicin—muscle cancer	0.00524	0.0706	CbGbCtD
Rimonabant—Mood alteration NOS—Methotrexate—muscle cancer	0.00057	0.0633	CcSEcCtD
Rimonabant—Lethargy—Dactinomycin—muscle cancer	0.000195	0.0217	CcSEcCtD
Rimonabant—Depression—Vincristine—muscle cancer	0.000132	0.0146	CcSEcCtD
Rimonabant—Cramp muscle—Etoposide—muscle cancer	0.000125	0.0139	CcSEcCtD
Rimonabant—Hallucination—Vincristine—muscle cancer	0.000118	0.0131	CcSEcCtD
Rimonabant—Hypoaesthesia—Vincristine—muscle cancer	0.000118	0.0131	CcSEcCtD
Rimonabant—Connective tissue disorder—Vincristine—muscle cancer	0.000116	0.0129	CcSEcCtD
Rimonabant—Angiopathy—Vincristine—muscle cancer	0.000107	0.0119	CcSEcCtD
Rimonabant—Infestation—Etoposide—muscle cancer	0.000107	0.0119	CcSEcCtD
Rimonabant—Infestation NOS—Etoposide—muscle cancer	0.000107	0.0119	CcSEcCtD
Rimonabant—Mediastinal disorder—Vincristine—muscle cancer	0.000107	0.0118	CcSEcCtD
Rimonabant—Mental disorder—Vincristine—muscle cancer	0.000104	0.0115	CcSEcCtD
Rimonabant—Hiccups—Doxorubicin—muscle cancer	9.91e-05	0.011	CcSEcCtD
Rimonabant—Hypoaesthesia—Etoposide—muscle cancer	9.54e-05	0.0106	CcSEcCtD
Rimonabant—Infection—Dactinomycin—muscle cancer	9.35e-05	0.0104	CcSEcCtD
Rimonabant—Anorexia—Dactinomycin—muscle cancer	8.97e-05	0.00996	CcSEcCtD
Rimonabant—Convulsion—Vincristine—muscle cancer	8.93e-05	0.00991	CcSEcCtD
Rimonabant—Angiopathy—Etoposide—muscle cancer	8.7e-05	0.00966	CcSEcCtD
Rimonabant—Mediastinal disorder—Etoposide—muscle cancer	8.64e-05	0.00959	CcSEcCtD
Rimonabant—Lethargy—Methotrexate—muscle cancer	8.47e-05	0.00941	CcSEcCtD
Rimonabant—Infection—Vincristine—muscle cancer	8.36e-05	0.00928	CcSEcCtD
Rimonabant—Nervous system disorder—Vincristine—muscle cancer	8.25e-05	0.00916	CcSEcCtD
Rimonabant—Decreased appetite—Dactinomycin—muscle cancer	8.18e-05	0.00908	CcSEcCtD
Rimonabant—Hyperhidrosis—Vincristine—muscle cancer	8.13e-05	0.00903	CcSEcCtD
Rimonabant—Fatigue—Dactinomycin—muscle cancer	8.12e-05	0.00901	CcSEcCtD
Rimonabant—Muscle spasms—Etoposide—muscle cancer	8.03e-05	0.00891	CcSEcCtD
Rimonabant—Anorexia—Vincristine—muscle cancer	8.02e-05	0.0089	CcSEcCtD
Rimonabant—Irritability—Methotrexate—muscle cancer	7.93e-05	0.0088	CcSEcCtD
Rimonabant—Mood swings—Methotrexate—muscle cancer	7.87e-05	0.00873	CcSEcCtD
Rimonabant—Gastrointestinal pain—Dactinomycin—muscle cancer	7.7e-05	0.00855	CcSEcCtD
Rimonabant—Hot flush—Doxorubicin—muscle cancer	7.69e-05	0.00853	CcSEcCtD
Rimonabant—Menopausal symptoms—Doxorubicin—muscle cancer	7.62e-05	0.00846	CcSEcCtD
Rimonabant—Insomnia—Vincristine—muscle cancer	7.61e-05	0.00845	CcSEcCtD
Rimonabant—Paraesthesia—Vincristine—muscle cancer	7.55e-05	0.00838	CcSEcCtD
Rimonabant—Abdominal pain—Dactinomycin—muscle cancer	7.44e-05	0.00826	CcSEcCtD
Rimonabant—Hypoglycaemia—Doxorubicin—muscle cancer	7.37e-05	0.00818	CcSEcCtD
Rimonabant—Lethargy—Doxorubicin—muscle cancer	7.34e-05	0.00815	CcSEcCtD
Rimonabant—Decreased appetite—Vincristine—muscle cancer	7.31e-05	0.00812	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Vincristine—muscle cancer	7.26e-05	0.00806	CcSEcCtD
Rimonabant—Fatigue—Vincristine—muscle cancer	7.25e-05	0.00805	CcSEcCtD
Rimonabant—Convulsion—Etoposide—muscle cancer	7.23e-05	0.00803	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Etoposide—muscle cancer	7.06e-05	0.00784	CcSEcCtD
Rimonabant—Abdominal discomfort—Methotrexate—muscle cancer	6.88e-05	0.00764	CcSEcCtD
Rimonabant—Gastrointestinal pain—Vincristine—muscle cancer	6.88e-05	0.00764	CcSEcCtD
Rimonabant—Mood swings—Doxorubicin—muscle cancer	6.81e-05	0.00756	CcSEcCtD
Rimonabant—Infection—Etoposide—muscle cancer	6.77e-05	0.00751	CcSEcCtD
Rimonabant—Asthenia—Dactinomycin—muscle cancer	6.76e-05	0.0075	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Methotrexate—muscle cancer	6.67e-05	0.0074	CcSEcCtD
Rimonabant—Abdominal pain—Vincristine—muscle cancer	6.65e-05	0.00738	CcSEcCtD
Rimonabant—Skin disorder—Etoposide—muscle cancer	6.62e-05	0.00735	CcSEcCtD
Rimonabant—Hyperhidrosis—Etoposide—muscle cancer	6.59e-05	0.00731	CcSEcCtD
Rimonabant—Anorexia—Etoposide—muscle cancer	6.5e-05	0.00721	CcSEcCtD
Rimonabant—Diarrhoea—Dactinomycin—muscle cancer	6.44e-05	0.00715	CcSEcCtD
Rimonabant—Infestation NOS—Methotrexate—muscle cancer	6.4e-05	0.0071	CcSEcCtD
Rimonabant—Infestation—Methotrexate—muscle cancer	6.4e-05	0.0071	CcSEcCtD
Rimonabant—Depression—Methotrexate—muscle cancer	6.38e-05	0.00708	CcSEcCtD
Rimonabant—Influenza—Doxorubicin—muscle cancer	6.21e-05	0.0069	CcSEcCtD
Rimonabant—Paraesthesia—Etoposide—muscle cancer	6.12e-05	0.00679	CcSEcCtD
Rimonabant—Asthenia—Vincristine—muscle cancer	6.04e-05	0.0067	CcSEcCtD
Rimonabant—Vomiting—Dactinomycin—muscle cancer	5.99e-05	0.00664	CcSEcCtD
Rimonabant—Rash—Dactinomycin—muscle cancer	5.94e-05	0.00659	CcSEcCtD
Rimonabant—Decreased appetite—Etoposide—muscle cancer	5.92e-05	0.00658	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Etoposide—muscle cancer	5.88e-05	0.00653	CcSEcCtD
Rimonabant—Fatigue—Etoposide—muscle cancer	5.87e-05	0.00652	CcSEcCtD
Rimonabant—Upper respiratory tract infection—Doxorubicin—muscle cancer	5.78e-05	0.00641	CcSEcCtD
Rimonabant—Diarrhoea—Vincristine—muscle cancer	5.76e-05	0.00639	CcSEcCtD
Rimonabant—Nausea—Dactinomycin—muscle cancer	5.59e-05	0.00621	CcSEcCtD
Rimonabant—Gastrointestinal pain—Etoposide—muscle cancer	5.57e-05	0.00619	CcSEcCtD
Rimonabant—Dizziness—Vincristine—muscle cancer	5.56e-05	0.00617	CcSEcCtD
Rimonabant—Infestation NOS—Doxorubicin—muscle cancer	5.54e-05	0.00615	CcSEcCtD
Rimonabant—Infestation—Doxorubicin—muscle cancer	5.54e-05	0.00615	CcSEcCtD
Rimonabant—Abdominal pain—Etoposide—muscle cancer	5.39e-05	0.00598	CcSEcCtD
Rimonabant—Vomiting—Vincristine—muscle cancer	5.35e-05	0.00594	CcSEcCtD
Rimonabant—Rash—Vincristine—muscle cancer	5.3e-05	0.00589	CcSEcCtD
Rimonabant—Dermatitis—Vincristine—muscle cancer	5.3e-05	0.00588	CcSEcCtD
Rimonabant—Headache—Vincristine—muscle cancer	5.27e-05	0.00585	CcSEcCtD
Rimonabant—Angiopathy—Methotrexate—muscle cancer	5.21e-05	0.00579	CcSEcCtD
Rimonabant—Sinusitis—Doxorubicin—muscle cancer	5.2e-05	0.00577	CcSEcCtD
Rimonabant—Mediastinal disorder—Methotrexate—muscle cancer	5.18e-05	0.00575	CcSEcCtD
Rimonabant—Mental disorder—Methotrexate—muscle cancer	5.03e-05	0.00559	CcSEcCtD
Rimonabant—Malnutrition—Methotrexate—muscle cancer	5e-05	0.00555	CcSEcCtD
Rimonabant—Nausea—Vincristine—muscle cancer	5e-05	0.00555	CcSEcCtD
Rimonabant—Hypoaesthesia—Doxorubicin—muscle cancer	4.95e-05	0.00549	CcSEcCtD
Rimonabant—Asthenia—Etoposide—muscle cancer	4.89e-05	0.00543	CcSEcCtD
Rimonabant—Connective tissue disorder—Doxorubicin—muscle cancer	4.89e-05	0.00543	CcSEcCtD
Rimonabant—Pruritus—Etoposide—muscle cancer	4.82e-05	0.00535	CcSEcCtD
Rimonabant—Diarrhoea—Etoposide—muscle cancer	4.66e-05	0.00518	CcSEcCtD
Rimonabant—Angiopathy—Doxorubicin—muscle cancer	4.51e-05	0.00501	CcSEcCtD
Rimonabant—Dizziness—Etoposide—muscle cancer	4.51e-05	0.005	CcSEcCtD
Rimonabant—Mediastinal disorder—Doxorubicin—muscle cancer	4.48e-05	0.00498	CcSEcCtD
Rimonabant—Mental disorder—Doxorubicin—muscle cancer	4.36e-05	0.00484	CcSEcCtD
Rimonabant—Convulsion—Methotrexate—muscle cancer	4.33e-05	0.00481	CcSEcCtD
Rimonabant—Vomiting—Etoposide—muscle cancer	4.33e-05	0.00481	CcSEcCtD
Rimonabant—Malnutrition—Doxorubicin—muscle cancer	4.33e-05	0.00481	CcSEcCtD
Rimonabant—Rash—Etoposide—muscle cancer	4.3e-05	0.00477	CcSEcCtD
Rimonabant—Dermatitis—Etoposide—muscle cancer	4.29e-05	0.00476	CcSEcCtD
Rimonabant—Headache—Etoposide—muscle cancer	4.27e-05	0.00474	CcSEcCtD
Rimonabant—Tension—Doxorubicin—muscle cancer	4.25e-05	0.00472	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—muscle cancer	4.23e-05	0.00469	CcSEcCtD
Rimonabant—Nervousness—Doxorubicin—muscle cancer	4.21e-05	0.00467	CcSEcCtD
Rimonabant—Muscle spasms—Doxorubicin—muscle cancer	4.16e-05	0.00462	CcSEcCtD
Rimonabant—Infection—Methotrexate—muscle cancer	4.05e-05	0.0045	CcSEcCtD
Rimonabant—Nausea—Etoposide—muscle cancer	4.05e-05	0.00449	CcSEcCtD
Rimonabant—Nervous system disorder—Methotrexate—muscle cancer	4e-05	0.00444	CcSEcCtD
Rimonabant—Skin disorder—Methotrexate—muscle cancer	3.96e-05	0.0044	CcSEcCtD
Rimonabant—Hyperhidrosis—Methotrexate—muscle cancer	3.95e-05	0.00438	CcSEcCtD
Rimonabant—Anorexia—Methotrexate—muscle cancer	3.89e-05	0.00432	CcSEcCtD
Rimonabant—Convulsion—Doxorubicin—muscle cancer	3.75e-05	0.00416	CcSEcCtD
Rimonabant—Insomnia—Methotrexate—muscle cancer	3.69e-05	0.0041	CcSEcCtD
Rimonabant—Anxiety—Doxorubicin—muscle cancer	3.67e-05	0.00408	CcSEcCtD
Rimonabant—Paraesthesia—Methotrexate—muscle cancer	3.67e-05	0.00407	CcSEcCtD
Rimonabant—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—muscle cancer	3.66e-05	0.00406	CcSEcCtD
Rimonabant—Dry mouth—Doxorubicin—muscle cancer	3.61e-05	0.004	CcSEcCtD
Rimonabant—Decreased appetite—Methotrexate—muscle cancer	3.55e-05	0.00394	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Methotrexate—muscle cancer	3.52e-05	0.00391	CcSEcCtD
Rimonabant—Fatigue—Methotrexate—muscle cancer	3.52e-05	0.00391	CcSEcCtD
Rimonabant—Infection—Doxorubicin—muscle cancer	3.51e-05	0.0039	CcSEcCtD
Rimonabant—Nervous system disorder—Doxorubicin—muscle cancer	3.47e-05	0.00385	CcSEcCtD
Rimonabant—Skin disorder—Doxorubicin—muscle cancer	3.43e-05	0.00381	CcSEcCtD
Rimonabant—Hyperhidrosis—Doxorubicin—muscle cancer	3.42e-05	0.00379	CcSEcCtD
Rimonabant—Anorexia—Doxorubicin—muscle cancer	3.37e-05	0.00374	CcSEcCtD
Rimonabant—Gastrointestinal pain—Methotrexate—muscle cancer	3.34e-05	0.0037	CcSEcCtD
Rimonabant—Abdominal pain—Methotrexate—muscle cancer	3.23e-05	0.00358	CcSEcCtD
Rimonabant—Insomnia—Doxorubicin—muscle cancer	3.2e-05	0.00355	CcSEcCtD
Rimonabant—Paraesthesia—Doxorubicin—muscle cancer	3.17e-05	0.00352	CcSEcCtD
Rimonabant—Decreased appetite—Doxorubicin—muscle cancer	3.07e-05	0.00341	CcSEcCtD
Rimonabant—Gastrointestinal disorder—Doxorubicin—muscle cancer	3.05e-05	0.00339	CcSEcCtD
Rimonabant—Fatigue—Doxorubicin—muscle cancer	3.05e-05	0.00338	CcSEcCtD
Rimonabant—Asthenia—Methotrexate—muscle cancer	2.93e-05	0.00325	CcSEcCtD
Rimonabant—Gastrointestinal pain—Doxorubicin—muscle cancer	2.89e-05	0.00321	CcSEcCtD
Rimonabant—Pruritus—Methotrexate—muscle cancer	2.89e-05	0.00321	CcSEcCtD
Rimonabant—Abdominal pain—Doxorubicin—muscle cancer	2.79e-05	0.0031	CcSEcCtD
Rimonabant—Diarrhoea—Methotrexate—muscle cancer	2.79e-05	0.0031	CcSEcCtD
Rimonabant—Dizziness—Methotrexate—muscle cancer	2.7e-05	0.003	CcSEcCtD
Rimonabant—Vomiting—Methotrexate—muscle cancer	2.6e-05	0.00288	CcSEcCtD
Rimonabant—Rash—Methotrexate—muscle cancer	2.57e-05	0.00286	CcSEcCtD
Rimonabant—Dermatitis—Methotrexate—muscle cancer	2.57e-05	0.00285	CcSEcCtD
Rimonabant—Headache—Methotrexate—muscle cancer	2.56e-05	0.00284	CcSEcCtD
Rimonabant—Asthenia—Doxorubicin—muscle cancer	2.54e-05	0.00281	CcSEcCtD
Rimonabant—Pruritus—Doxorubicin—muscle cancer	2.5e-05	0.00278	CcSEcCtD
Rimonabant—Nausea—Methotrexate—muscle cancer	2.42e-05	0.00269	CcSEcCtD
Rimonabant—Diarrhoea—Doxorubicin—muscle cancer	2.42e-05	0.00268	CcSEcCtD
Rimonabant—Dizziness—Doxorubicin—muscle cancer	2.34e-05	0.00259	CcSEcCtD
Rimonabant—Vomiting—Doxorubicin—muscle cancer	2.25e-05	0.00249	CcSEcCtD
Rimonabant—Rash—Doxorubicin—muscle cancer	2.23e-05	0.00247	CcSEcCtD
Rimonabant—Dermatitis—Doxorubicin—muscle cancer	2.23e-05	0.00247	CcSEcCtD
Rimonabant—Headache—Doxorubicin—muscle cancer	2.21e-05	0.00246	CcSEcCtD
Rimonabant—Nausea—Doxorubicin—muscle cancer	2.1e-05	0.00233	CcSEcCtD
